Ordinary Adjustment | Solactive Healthcare Index | Effective Date 4th October 2024
Solactive Healthcare Index:
In the ordinary adjustment, the following composition will be implemented effective open 4th October 2024:
TAKEDA PHARMACEUTICAL |
CHUGAI PHARMACEUTICAL CO LTD ORD |
DAIICHI SANKYO CO LTD ORD |
FUJIFILM HOLDINGS CORP ORD |
HOYA CORP ORD |
AGILENT TECHNOLOGIES INC |
ABBVIE INC |
ABBOTT LABORATORIES |
ALCON INC |
ALNYLAM PHARMACEUTICALS INC |
AMGEN INC |
ARGENX SE – ADR |
ASTRAZENECA PLC |
BECTON DICKINSON AND CO |
BIOGEN INC |
BRISTOL-MYERS SQUIBB CO |
BOSTON SCIENTIFIC CORP |
THE CIGNA GROUP |
CENTENE CORP |
CSL LTD ORD |
DANAHER CORP |
ELEVANCE HEALTH INC |
ESSILORLUXOTTICA |
EDWARDS LIFESCIENCES CORP |
GE HEALTHCARE TECHNOLOGIES INC |
GILEAD SCIENCES INC |
GSK PLC |
HCA HEALTHCARE INC |
HUMANA INC |
IDEXX LABORATORIES INC |
IQVIA HOLDINGS INC |
INTUITIVE SURGICAL INC |
JOHNSON & JOHNSON |
ELI LILLY & CO |
LONZA GROUP AG |
MEDTRONIC PLC |
MERCK & CO. INC. |
METTLER-TOLEDO INTL |
NOVARTIS AG |
NOVO NORDISK A/S |
PFIZER INC |
REGENERON PHARMACEUTICALS |
RESMED INC |
ROCHE HOLDING AG |
SANOFI SA |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |
ZOETIS INC |